Intercept Pharmaceuticals (ICPT) PT Raised to $146 at Wells Fargo
Tweet
Share
E-mailGet Alerts ICPT Hot Sheet
Price: $19.00 --0%
Rating Summary:
13 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
13 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Wells Fargo analyst Jim Birchenough raised the price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $146.00 (from $120.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Central Retail Corp PCL (CRC:TB) PT Lowered to THB9,000 at Macquarie
- Ashok Leyland Ltd. (AL:IN) PT Raised to INR194 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
